尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the full record of transactions filed by Pakianathan Deepika, 董事. Insider active across 5 companies, notably Pardes Biosciences, INC.. Aggregated, 11 reports have been published. Split: 0 buy · 4 sells. Total volume traded: €2.5m. History available since 23 December 2021. The latest transaction was filed on 19 May 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 条申报中的 11 条
PAKIANATHAN DEEPIKA is Administrateur and has 11 filings in total. Across the 11 sampled filings, the reported volumes are 0 EUR of buys and 2,545,493 EUR of sells, with filings dated from 2021-12-28 to 2025-05-21. She is linked to Theravance Biopharma, Inc., Karyopharm Therapeutics Inc., Pardes Biosciences, INC., Mereo BioPharma Group plc and Calithera Biosciences, Inc.